Using impedance-based monitoring, we present the first characterization of two human mesencephalic fetal neural stem lines (LUHMES and hVM1 Bcl-XL) that have been developed for the study of the pathogenesis of Parkinson’s disease and its treatment by cell replacement therapy (CRT). This evidence concerns the gene BCL2L1 and Parkinson disease.